Unfortunately, my experience with prior authorization from insurance companies is not unique, writes guest columnist Sheldon ...
QIVIGY is the realization of over 10 years of investments and internal efforts to bring a proprietary IVIG product from ...
During year 6 of continuous treatment with BRIUMVI the annualized relapse rate was 0.012, equivalent to one relapse occurring every 83 years of ...
In clinical trials, Imaavy plus standard therapy improved muscle strength and daily function in adults and adolescents with generalized myasthenia gravis.
NPPA releases draft calculation sheet with ceiling price of six scheduled formulations: Gireesh Babu, New Delhi Monday, ...
Thea Barnett from Penryn is thought to be the "only child in the UK" with a rare variant of Primary Immunodeficiency.
KabaFusion (the "Company"), a nationally recognized leader in home and alternative site infusion, and Nautic Partners ("Nautic") announced today that Nautic has signed a definitive agreement to make a ...
HyHub and HyHub Duo Reduce the Number of Steps Required to Prepare HYQVIA1 First Devices Customized for a Plasma-Derived Therapy in Takeda’s Broad and Differentiated Portfolio Reflect Company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback